Haidong Xu

4.6k total citations · 2 hit papers
65 papers, 3.5k citations indexed

About

Haidong Xu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Haidong Xu has authored 65 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cancer Research and 18 papers in Epidemiology. Recurrent topics in Haidong Xu's work include NF-κB Signaling Pathways (15 papers), Autophagy in Disease and Therapy (14 papers) and Immune Response and Inflammation (13 papers). Haidong Xu is often cited by papers focused on NF-κB Signaling Pathways (15 papers), Autophagy in Disease and Therapy (14 papers) and Immune Response and Inflammation (13 papers). Haidong Xu collaborates with scholars based in China, United States and Japan. Haidong Xu's co-authors include Zheng‐Hong Qin, Jiandong Li, Zixu Mao, Hirofumi Kai, Jae Hyang Lim, Hirofumi Jono, Gaolin Liang, Xiaotong Cheng, Fu‐Gen Wu and Huan-Huan Ran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Haidong Xu

63 papers receiving 3.5k citations

Hit Papers

Glutathione-Depleting Nanomedicines for Synergistic Cance... 2019 2026 2021 2023 2021 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haidong Xu China 33 1.5k 991 780 742 334 65 3.5k
Baldur Sveinbjørnsson Norway 40 1.9k 1.3× 657 0.7× 620 0.8× 1.0k 1.4× 257 0.8× 109 4.3k
Jiang Huai Wang Ireland 34 939 0.6× 361 0.4× 391 0.5× 1.2k 1.6× 314 0.9× 86 3.2k
Hideaki Ito Japan 34 2.2k 1.4× 1.3k 1.3× 614 0.8× 429 0.6× 380 1.1× 169 5.0k
Флориан Грубер Austria 38 2.1k 1.4× 654 0.7× 529 0.7× 1.2k 1.6× 223 0.7× 95 4.6k
Yue Zhang China 33 2.0k 1.3× 310 0.3× 977 1.3× 426 0.6× 240 0.7× 170 3.6k
Akiko Eguchi Japan 36 3.3k 2.2× 2.0k 2.0× 902 1.2× 606 0.8× 224 0.7× 108 5.2k
Fengyi Wan United States 26 2.0k 1.4× 1.3k 1.3× 516 0.7× 995 1.3× 114 0.3× 47 4.3k
Kui Zhang China 37 2.4k 1.6× 365 0.4× 740 0.9× 794 1.1× 465 1.4× 188 4.5k
Qianqian Zhu China 35 1.9k 1.3× 458 0.5× 938 1.2× 549 0.7× 241 0.7× 159 3.9k
Lin Xiao China 31 2.5k 1.7× 554 0.6× 598 0.8× 582 0.8× 261 0.8× 87 4.2k

Countries citing papers authored by Haidong Xu

Since Specialization
Citations

This map shows the geographic impact of Haidong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haidong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haidong Xu more than expected).

Fields of papers citing papers by Haidong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haidong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haidong Xu. The network helps show where Haidong Xu may publish in the future.

Co-authorship network of co-authors of Haidong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Haidong Xu. A scholar is included among the top collaborators of Haidong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haidong Xu. Haidong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hao, Haidong Xu, Li Zhang, et al.. (2025). Electrocatalysis for liquid chemical hydrogen storage. Coordination Chemistry Reviews. 534. 216562–216562. 7 indexed citations
2.
Liu, Xiaoyang, Qiaochu Jiang, Haidong Xu, et al.. (2025). Cell Membrane-Anchored Click Reaction Enhances Porphyrin Uptake for Highly Efficient Photodynamic Therapy of Breast Tumors. Journal of the American Chemical Society. 147(45). 41657–41667. 2 indexed citations
3.
Gao, Ge, Yao‐Wen Jiang, Jiaxuan Chen, et al.. (2024). Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response. Advanced Materials. 36(23). e2312153–e2312153. 22 indexed citations
4.
Xu, Haidong, et al.. (2024). Consecutive Year-by-Year Planning of Grid-Side Energy Storage System Considering Demand-Side Response Resources. Energies. 17(15). 3639–3639. 1 indexed citations
5.
Sun, Xianbao, Manli Wang, Xiaoyang Liu, et al.. (2023). Enzymatic self-assembly/disassembly turns “ON”/“OFF” the mimetic hydrolytic activity of histidine nanofibers. Science China Chemistry. 67(2). 517–522. 3 indexed citations
6.
Sun, Xianbao, Lingling Xu, Xiaoyang Liu, et al.. (2023). Activatable small molecular luminescence probes for autofluorescence-free bioimaging. TrAC Trends in Analytical Chemistry. 168. 117326–117326. 9 indexed citations
7.
Komatsu, Kensei, Byung-Cheol Lee, Masanori Miyata, et al.. (2022). Negative Cross-Talk between TLR2/4-Independent AMPKα1 and TLR2/4-Dependent JNK Regulates S. pneumoniae–Induced Mucosal Innate Immune Response. The Journal of Immunology. 209(8). 1532–1544. 3 indexed citations
8.
Li, Wenming, Juan Dou, Jing Yang, Haidong Xu, & Hua She. (2018). Targeting Chaperone-Mediated Autophagy for Disease Therapy. Current Pharmacology Reports. 4(3). 261–275. 6 indexed citations
9.
Li, Wenming, et al.. (2018). Chaperone-mediated autophagy: Advances from bench to bedside. Neurobiology of Disease. 122. 41–48. 29 indexed citations
10.
Li, Bin, Junjie Guan, Haidong Xu, et al.. (2017). Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells. Acta Pharmacologica Sinica. 38(9). 1305–1316. 47 indexed citations
11.
Miyata, Masanori, Ji-Yun Lee, Haidong Xu, et al.. (2015). Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. Nature Communications. 6(1). 6062–6062. 98 indexed citations
12.
Xu, Haidong, Chungyoul Choe, Seung–Hun Shin, et al.. (2014). Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27Kip1 ubiquitination pathway in hepatocellular carcinoma. Experimental & Molecular Medicine. 46(5). e97–e97. 43 indexed citations
13.
Xu, Haidong, et al.. (2013). Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma. Cell Biochemistry and Biophysics. 69(2). 319–325. 26 indexed citations
14.
Xu, Haidong, et al.. (2013). Tumor-Suppressing Effects of miR451 in Human Osteosarcoma. Cell Biochemistry and Biophysics. 69(1). 163–168. 67 indexed citations
15.
Xu, Xiangbin, Jinjiang Pang, Ji-Yun Lee, et al.. (2011). Activation of Epidermal Growth Factor Receptor Is Required for NTHi-Induced NF-κB-Dependent Inflammation. PLoS ONE. 6(11). e28216–e28216. 29 indexed citations
16.
Zhu, Yushan, Lixia Zhao, Lei Liu, et al.. (2010). Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein & Cell. 1(5). 468–477. 205 indexed citations
17.
Koga, Tomoaki, Jae Hyang Lim, Hirofumi Jono, et al.. (2008). Tumor Suppressor Cylindromatosis Acts as a Negative Regulator for Streptococcus pneumoniae-induced NFAT Signaling. Journal of Biological Chemistry. 283(18). 12546–12554. 45 indexed citations
18.
Ishinaga, Hajime, Hirofumi Jono, Jae Hyang Lim, et al.. (2007). TGF‐β induces p65 acetylation to enhance bacteria‐induced NF‐κB activation. The EMBO Journal. 26(4). 1150–1162. 83 indexed citations
19.
Lim, Jae Hyang, Hirofumi Jono, Tomoaki Koga, et al.. (2007). Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice. PLoS ONE. 2(10). e1032–e1032. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026